Immucell (ICCC) EV to CFO (2010 - 2025)
Immucell's (ICCC) quarterly EV to CFO came in at 107.4 in Q4 2025, up 100.77% on a YoY basis from 53.49 in Q4 2024, and up 341.23% quarter-over-quarter from 44.52 in Q3 2025.
Powered by 
Analysis
Immucell (ICCC) EV to CFO (2010 - 2025) Analysis & Trends
Immucell (ICCC) has reported EV to CFO for 16 consecutive years, with 107.4 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, EV to CFO rose 100.77% year-over-year to 107.4; the trailing twelve-month figure through Dec 2025 stood at 20.94 (down 82.36% YoY), and the FY2025 full-year result was 20.94, down 82.36% from the prior year.
- EV to CFO climbed to 107.4 in Q4 2025 per ICCC's latest filing, from 44.52 in the prior quarter.
- Across five years, EV to CFO topped out at 239.27 in Q3 2021 and bottomed at 13924.64 in Q4 2024.
- Historically, EV to CFO has averaged 669.76 across 5 years, with a median of 5.53 in 2023.
- The widest YoY moves for EV to CFO: up 817.97% in 2024, down 26070.21% in 2024.
- Over 5 years, EV to CFO stood at 88.03 in 2021, then plunged by 136.3% to 31.95 in 2022, then slumped by 66.54% to 53.21 in 2023, then slumped by 26070.21% to 13924.64 in 2024, then surged by 100.77% to 107.4 in 2025.
- According to Business Quant data, EV to CFO over the past three periods registered 107.4, 44.52, and 35.57 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 42.23 Bn | 42.03 Bn | 779.09 Mn |
| 2 | Zoetis | 31.39 Bn | 29.72 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 12.21 Bn | 11.68 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.55 Bn | 1.47 Bn | 134.40 Mn |
| 5 | Immucell | 89.91 Mn | 81.05 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.30 Mn | 77.22 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 107.40 |
| Sep 30, 2025 | -44.52 |
| Jun 30, 2025 | 35.57 |
| Mar 31, 2025 | 24.42 |
| Dec 31, 2024 | -13,924.64 |
| Sep 30, 2024 | -44.20 |
| Jun 30, 2024 | 63.02 |
| Mar 31, 2024 | 95.86 |
| Dec 31, 2023 | -53.21 |
| Sep 30, 2023 | -77.55 |
| Jun 30, 2023 | -54.71 |
| Mar 31, 2023 | -13.35 |
| Dec 31, 2022 | -31.95 |
| Sep 30, 2022 | -39.04 |
| Jun 30, 2022 | 150.69 |
| Mar 31, 2022 | 98.51 |
| Dec 31, 2021 | 88.03 |
| Sep 30, 2021 | 239.27 |
| Jun 30, 2021 | 85.99 |
| Mar 31, 2021 | -100.72 |